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Background: Musculoskeletal disorders (MSDs) are a major reason for impaired work productivity and sick leave. In
2009, a national rehabilitation program was introduced in Sweden to promote work ability, and patients with MSDs
were offered multimodal rehabilitation. The aim of this study was to analyse the effect of this program on health
related quality of life, function, sick leave and work ability.
Methods: We conducted a prospective, observational cohort study including 406 patients with MSDs attending
multimodal rehabilitation. Changes over time and differences between groups were analysed concerning function,
health related quality of life, work ability and sick leave. Regression analyses were used to study the outcome
variables health related quality of life (measured with EQ-5D), and sick leave.
Results: Functional ability and health related quality of life improved after rehabilitation. Patients with no sick leave/
disability pension the year before rehabilitation, improved health related quality of life more than patients with sick
leave/disability pension the year before rehabilitation (p = 0.044). During a period of −/+ four months from
rehabilitation start, patients with EQ-5D ≥ 0.5 at rehabilitation start, reduced their net sick leave days with 0.5 days
and patients with EQ-5D <0.5 at rehabilitation start, increased net sick leave days with 1.5 days (p = 0.019). Factors
negatively associated with sick leave at follow-up were earlier episodes of sick leave/disability pension, problems
with exercise tolerance functions and mobility after rehabilitation. Higher age was associated with not being on sick
leave at follow-up and reaching an EQ-5D ≥ 0.5 at follow-up. Severe pain after rehabilitation, problems with exercise
tolerance functions, born outside of Sweden and full-time sick leave/disability pension the year before rehabilitation
were all associated with an EQ-5D level < 0.5 at follow-up.
Conclusions: Patients with MSDs participating in a national work promoting rehabilitation program significantly
improved their health related quality of life and functional ability, especially those with no sick leave. This shows
that vocational rehabilitation programs in a primary health care setting are effective. The findings of this study can
also be valuable for more appropriate patient selection for rehabilitation programs for MSDs.
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In western countries, musculoskeletal disorders (MSD) are
a major reason for work ability limitations and sick leave
[1-3] and causes about one third of the total amount certi-
fied sick leave [4]. Musculoskeletal disorders are affected
by psychosocial factors; both at start and in the disease
course [5,6].
In the late 90s and turn of the century, there was a
steady increase in the amount of people sick-listed in
Sweden. The same trend was seen also in Norway and the
Netherlands [7]. To break the trend, different changes in
the systems have been made [8-12] and major resources
been transferred from the social insurance system to the
health care system, as incentives to improve rehabilitation
and sick leave management. From 2009, approximately
one hundred million Euros have been available on a yearly
basis for the regional health authorities to improve the
sick-listing process [13].
A structured rehabilitation time-schedule was introduced,
which highlighted the employer’s responsibilities and also
how work ability should be assessed and improved [11].
Another major reform was the introduction of a structured,
national rehabilitation program, aiming at promoting work
ability, by offering early, evidence-based rehabilitation
directed to and ensured for patients with mild to moderate
mental disorders and persons with MSD, mainly neck,
shoulder and back pain [10]. For patients with MSD, multi-
modal rehabilitation (MMR) was offered after referral from
primary health care (PHC) system. Different MMR pro-
grams have been evaluated during the past years and MMR
has been found to be effective on return to work (RTW)
[14] and cost-effective [15]. Combining MMR and work
place interventions are found effective on RTW [16,17].
The concept of work ability is complex [18-21] and
there are also divergent interpretations [22,23]. Different
health professionals experience work ability as difficult
to assess [22,24-27] and there are no single measure that
can capture all factors contributing to work ability [28].
Therefore it is important to evaluate different outcomes
related to work ability to better understand the concept.
In this study we focus on work ability in a broader per-
spective. The aim of this study was to study the out-
comes of MMR in a national rehabilitation program and
associated factors of changes in health related quality of
life (HRQoL) and sick leave.
Method
We conducted an explorative, prospective observational
study in a well-defined cohort and linked this to register
data on sick leave.
Setting and procedure
In Sweden, the responsibility for providing health care is
decentralised to the county councils. Both public andprivate health care providers have the same tax-based fi-
nancing system and apart from a small co-pay the resi-
dents are entitled to free health care. Skåne County
(Region Skåne) is the southernmost part of Sweden with a
population of 1.3 million inhabitants, which correspond to
1/8 of the total Swedish population and is representative
for the whole Swedish population, in terms of demogra-
phics. The Skåne Health Care Register (SHCR) contains
routinely collected data of all health care in the region. All
data is on an individual level, coded by personal identi-
fication number (PIN), a unique number automatically
assigned to all residents. In this study, data collection took
place in a natural setting at different PHC centres in the
county; both private and public. Patients with MSD, seek-
ing PHC were offered MMR, through the national
rehabilitation program and were followed with self-
administered questionnaires at MMR start and after fin-
ished MMR. A three month follow-up was also conducted.
A questionnaire, completed by health care professionals,
was answered at MMR start and after completed MMR.
Also basic demographic data was collected and each
patient consultation was registered with date, type of treat-
ment and profession. The parameters were consecutively
reported from different health care providers. These regis-
trations were linked to economical compensations for the
PHC centres and also for the purpose of provide follow-
ups for the responsible authority and to the particular
health care unit.
In Sweden, sick leave insurances include the whole work-
ing population from the age of 16 or older, and are tax-
financed from day 15. Sick leave data was obtained from
the Swedish Social Insurance Agency (SSIA) (Figure 1).
Patients
The setting of patients was a pre-defined cohort of all
patients that had been consecutively notified for MMR in
Skåne County, during September 2009 and until August
2010. The cohort included 724 patients with MSD. This is
the first cohort of patients that had access to MMR
through the national rehabilitation program [10]. In line
with the intention of the intervention, patients receiving at
least six treatments for a period of at least six weeks were
included, which resulted in 637 patients. To be able to link
sick leave data to patient data, all patients were sent a
letter of consent with opt-out opportunity. In total 43
patients decided not to participate. Sick leave data from
SSIA were linked for the remaining 594 patients. Five
patients not registered in Region Skåne, one year before
MMR start, were excluded. To stay close to the intention
of the National rehabilitation program, patients that had a
rehabilitation period lasting for more than 26 weeks were
excluded and also those patients that had invalid time
series for date registrations. The final study cohort con-
sisted of 406 patients (Figure 2).
Figure 1 Flowchart of outcomes.
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MMR comprised of evidence-based assessments and re-
habilitation interventions [10]. At least three different
professionals must be included in the team, whereof
one had to be a physician. The interventions must last
for minimum six weeks, two-three times a week and
should be coordinated.Figure 2 Flowchart on inclusion and exclusion in the cohort.Outcomes
Self-reported health related quality of life (HRQoL)
The self-administered, generic questionnaire EQ-5D was
used [29,30] and in this study the five-question part was
analysed. Each question has three answering alternatives;
1–3, and 1 correspond to no problems. The answers were
merged into one total EQ-5D from −0.59 -1, according to
the United Kingdom (UK) tariff (since no tariff for Sweden
is available) and 1 correspond to full HRQoL [31-33].
Self-reported work ability
All patients that had an employment or were self-employed
answered a question if they perceived work ability limita-
tions the last week, while at work and due to pain (yes/no).
Function
The health care professionals answered questions about
their evaluation of the patient’s functional limitations,
grounded on International Classification of Functioning,
Disability and Health (ICF) [34]. These questions graded
sensation of pain (b280), problems with exercise toler-
ance functions (b455) and mobility of joint functions
(b710). The answering alternatives were graded in five
steps, from no limitation (0) to total limitation (4).
Sick leave data
Sick leave data for a period of 12 month before MMR start
and four month after MMR start were collected from the
register at SSIA. This data were reported in different types
of compensations and reported as disability pension (DP),
total sick leave (SL), which includes sick leave in preven-
tion, work related injury compensation and rehabilitation
compensation. Total burden of sick compensations
(SLDP) was also reported. SLDP may comprise both SL
and DP or only one of the compensations. SL and DP
were reported in net days (net days computed as full
working days of sick leave compensation, i.e., two half days
of SL (or DP) correspond to one full net day) for each
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prevalence. New episodes on SL or DP were also reported.Analysis
Grouping and organisation of data
When describing characteristics of the study population,
comparing functions and EQ-5D, the cohort was divided
in three different groups, based on the total burden of net
days SLDP the year before MMR; no SLDP, part-time
SLDP (< 360 days) and full-time SLDP (≥360 days). When
comparing SL, the group was divided in having an EQ-5D
< or ≥ 0.5 at MMR start. Diagnoses were registered
according to the Swedish translation of International Clas-
sification of Diseases and Related Health Problems (ICD)
10 system [35] and grouped together and presented in
four different groups; myalgia or pain (M791, M799P,
R52) neck-shoulder pain (M42, M530, M531, M50-,
M750, M751, M754, M759P, T918A,), back pain (M51,
M533, M543, M544, M545, M546, M549P) and rheuma-
tism UNS (M790) (Table 1).
Before regression analyses, variables with several differ-
ent answering alternatives were grouped together so there
were no more than three different alternatives for each
variable. The first level served as reference value (1). The
continuous variable age, were dichotomised in < 40 years
respectively ≥ 40 years and EQ-5D into < 0.5 or ≥ 0.5. In
the regression analyses of sick leave at month four after
MMR start, patients with full-time DP the year before
MMR (n = 45) were excluded from the cohort. In the vari-
able SLDP episodes the year before MMR start, patients
with part-time DP were counted as having one episode.Table 1 Baseline characteristics of the study population (n = 4
No Part-tim
n = 123 n = 214
n % Mean SD n
Age 42.51 10.15
Women/men 94/29 76.4/23.6 174/4
Born in Sweden y/n 102/21 82.9/17.1 165/4
Married y/n 65/68 52.8/47.2 120/9
Children home y/n 73/50 59.3/40.7 117/9
Empl/self-empl y/n 84/39 68.3/31.7 148/6
Education
No/elementary school 15 12.2 4
Upper sec school 66 53.7 12
University 42 34.1 4
Diagnos
Myalgia and pain 62 50.4 9
Neck-shoulder pain 26 21.1 4
Back pain 31 25.2 6
Rheumatism UNS 4 3.3 1Statistical analyses
Descriptive statistics were presented by their frequencies
and significances were evaluated by the Chi-Square test
and independent sample t-test, when comparing means.
Paired sample t-test was used when analysing mean dif-
ferences over time. The Mann–Whitney Test was used
when comparing ordinal data over time and between
group differences. Changes in functions were merged
into improved, not improved and impaired, before com-
paring groups. Independent sample t-test and paired
sampled t-test were used to compare differences within
and between groups. To find out about associated fac-
tors for sick leave at month four after MMR start and
EQ-5D < or ≥ 0.5 at follow-up, regression analyses were
performed. The crude model was comprised of univari-
ate regression analyses for each variable. Model I was
comprised of variables on function and HRQoL at MMR
start and completed MMR, and backward regression
analysis was performed. In model II, adjustments were
made for background characteristics. The results are
presented in odds ratio (OR), confidence interval 95%
(CI) and also Nagelkerke, R2, for model precision of
outcome. Significant p-values (< 0.05) are marked in
bold face [36,37]. Data were analysed with IBM Statis-
tical software Package for the Social Sciences (SPSS),
version 20.0.Ethics
This study has been approved by the Regional Ethical
Review Board in Lund Dnr 2011/169 and approved by
Skåne County health care authorities was also received.06)
e Full-time
n = 69
% Mean SD n % Mean SD
45.76 9.82 47.71 8.22
0 81.3/18.7 56/13 81.2/18.8
9 77.1/22.9 43/26 62.3/37.7
4 56.1/43.9 35/34 50.7/49.3
7 54.7/45.3 37/32 53.6/46.4
6 69.2/30.8 17/52 24.6/75.4
5 21.0 20 29.0
6 58.9 39 56.5
3 20.1 10 14.5
0 42.0 39 56.6
7 22.0 12 17.4
1 28.5 13 18.8
6 7.5 5 7.2
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Baseline demographics
The study cohort (n = 406) consisted of 20.2% men and
79.8% women, with a mean age of 45.1 (SD 9.83)
(Table 1). Patients with no SLDP the year before MMR,
were slightly younger than patients with part-time SLDP
(p = 0.004) and patients with full-time SLDP (p < 0.000).
The group with no SLDP had higher education level
compared to the group with part-time SLDP (p = 0.007)
and the group with full-time SLDP (p < 0.001). Patients
with full-time SLDP the year before MMR were to a
greater extent not employed/self-employed (75.4%),
than both the other groups (p < 0.000). These patients
were also to a higher extent born outside Sweden com-
pared to no SLDP (p = 0.001) and those with part-time
SLDP (p = 0.016).
There were no differences in how symptoms were dis-
tributed when comparing the three groups based on
SLDP, but there were gender differences. Most women
had myalgia or pain (49.4%) whilst for men, back pain
and myalgia or pain were most common and equally
distributed (36.1% each).
At MMR start, 6.4% of the whole group was on sick
leave in prevention, as they were part of rehabilitation
for purpose of preventing future sick leave or shorten-
ing an on-going sick leave spell. 36.7% were on SL,
25.4% had DP and 44.1% had no SLDP. The total bur-
den of SL and DP for each person, one year before
MMR, was mean144 net days (SD 141.50), where 73.4
net days (SD 73.37) corresponded to SL and 70.6 (SD
12.47) net days to DP. No gender differences were
noted.
The original cohort comprised of 724 patients and
318 patients were excluded from the cohort, (Figure 2)
of which 22.6% were men and 77.4% women. Mean age
was 45.0 years (SD 10.73), which is in line with the final
study cohort. Register data on sick-leave was not avail-
able for the pre-defined original cohort.Multimodal rehabilitation (MMR)
The patients had a MMR period of mean 94.3 days (SD
38.76) and had mean 17.4 treatments (SD 7.13). The
group with no SLDP had just over two visits fewer com-
pared to the group with part-time SLDP (p = 0.005) and
full-time SLDP (p = 0.011). Physicians (40.8%) and phy-
siotherapists (34.4%) were the most common profes-
sionals when registering for MMR and also discharging
MMR (43.6% resp. 33.5%). Also other health care pro-
fessionals as psychologists and occupational therapists
were involved in MMR but physiotherapists were the
most frequently occurring health care professional.
Three or more different health care professionals were
involved in 62% of the patients’ rehabilitation.Health related quality of life
EQ-5D at MMR start, after completed MMR and at
follow-up differed between the groups with no, part-
time and full-time SLDP (Figure 3). There were signifi-
cant improvements between MMR start and completed
MMR within all three groups and for the group with
part-time SLDP, there was a slight improvement between
completed MMR and follow-up (p = 0.035). The group
with no SLDP improved more between MMR start and
completed MMR compared to the group with part-time
SLDP (p = 0.044) and also full-time SLDP (p = 0.044). No
differences in improvement, between the three groups
were seen between completed MMR and three month
follow-up.
Function
All functions were assessed as improved between MMR
start and completed MMR, for all three groups (Table 2).
There were differences in pain at MMR start, between
the group with no and full-time SLDP (p < 0.000). Also
at completed MMR there were differences in pain
between no and part-time SLDP (p < 0.000) and no and
full-time SLDP (p < 0.000). There were differences in
improvement between the three groups (p<0.000).
Exercise tolerance functions were different when
comparing no and full-time SLDP, both at MMR start
(p = 0.005) and completed MMR (p < 0.000). Also when
comparing the group with no and part-time SLDP, exer-
cise tolerance functions were different at completed
MMR (p < 0.000). There were also differences between
the group with part-time and full-time SLDP (p = 0.001).
There were no differences between the three groups, in
improvement of exercise tolerance functions (p= 0.054).
Mobility of joints functions were different when
comparing the group with no SLDP and full-time SLDP
at MMR start (p = 0.001) and at completed MMR
(p < 0.000). At MMR start, there were also differences
between no and part-time SLDP (p = 0.001). There were
differences in improvement between the three groups
(p= 0.037).
Sick leave and disability compensations
Comparisons were made between patients with EQ-5D
< 0.5 respectively ≥ 0.5, at MMR start. There were no dif-
ferences in net SL days four months before MMR start,
but the group with EQ-5D < 0.5 had more net SL days at
+/− two weeks from MMR start t (p = 0.002) and four
month after MMR start (p = 0.003). Also, there were
differences between the groups, in how net SL days
developed for the period month four before MMR until
MMR start (p = 0.037) and also for the whole period
(p = 0.057) (Figure 4). In the group with EQ-5D ≥ 0.5,
net SL days decreased with mean 0.5 days (SD10.28)
under the period from month four before MMR start
Figure 3 Health related quality of life (HRQoL) measured by EQ-5D. Mean HRQoL at multimodal rehabilitation (MMR) start (IN), completed
MMR (OUT) and at three month follow-up (FU), in patients with no (n = 123), part-time (n = 214) or full-time (n = 69) sick leave/disability pension
(SLDP) the year before MMR. 1 EQ-5D = 0.84, a Swedish normal population in two counties. 95% confidence interval (CI).
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group with EQ-5D < 0.5 net SL days increased with
mean 1.5 days (SD 10.08 ) (p = 0.019).
Work ability
In all three groups (no, part-time or full-time SLDP)
patients reported work ability limitations at MMR start,
73.6, 76.2 and 61.1% respectively (Figure 5). When com-
paring the three groups, there were no significant differ-
ences in work ability limitations at MMR start. After
completed MMR, there were differences between the
groups. In the group with no SLDP, 34.1% reported work
ability limitations, compared to 56.9% in the group with
part-time SLDP (p = 0.001) and 61.1% in the group with
full-time SLDP (p = 0.032). When comparing the group
with part-time and full-time SLDP, no differences were
seen at completed MMR (p = 0.736). At follow-up, 35.5%
in the group with no SLDP reported work ability limi-
tations, compared to 58.6% of those with part-time
SLDP (p =0.001) and 66.7% of those with full-time SLDP
(p = 0.022), but no differences were seen between part-
time and full-time SLDP (p =0.544).
Factors associated with EQ-5D < or ≥ 0.5 at three month
follow-up
In the crude model, functional limitations at MMR start
and completed MMR were associated with EQ-5D < 0.5.
Full SLDP the year before MMR and background fac-
tors, such as not being born in Sweden and being
un-employed was also associated with EQ-5D < 0.5.
University education was significantly associated with
EQ-5D ≥ 0.5.
In model I (R2 = 0.19) more severe sensation of pain at
completed MMR, moderate and more severe problems
with exercise tolerance functions at MMR start weresignificantly associated with having an EQ-5D < 0.5 at
three month follow up.
In the final, adjusted model II (R2 = 0.28) more severe
sensation of pain at completed MMR (OR 0.2, CI 0.1–0.5,
p < 0.000), moderate (OR 0.5, CI 0.3–0.9, p = 0.032) and
more severe (OR 0.4, CI 0.2–0.8, p = 0.012) problems with
exercise tolerance functions, being on full-time SLDP the
year before MMR (OR 0.4, CI 0.2–0.9, p = 0.027), not
being born in Sweden (OR 0.4, CI 0.2–0.6, p < 0.000) were
significantly associated with an EQ-5D < 0.5 at three
month follow-up. Being older than 40 years (OR 1.8, CI
1.1–3.1, p = 0.026) was significantly associated with having
an EQ-5D ≥ 0.5 at three month follow-up (Table 3).Factors associated with- sick leave at month four after
MMR
In the crude model, different functional limitations both
at MMR start and completed MMR, and also previous
SLDP-episodes were associated with sick leave at month
four. EQ-5D ≥ 0.5 at MMR start and at completed MMR
were both associated with not being on SL month four
after MMR (Table 4).
In model I (R2 = 0.14), moderate problems with exer-
cise tolerance functions at completed MMR, moderate
and more severe problems with mobility in joints func-
tions at completed MMR were associated with being on
SL month four after MMR.
In the final, adjusted model II (R2 = 0.31), moderate
problems with exercise tolerance functions (OR 2.2, CI
1.2–4.0, p = 0.009) at completed MMR, more severe pro-
blems with mobility in joints functions at completed
MMR (OR 2.6, CI 1.2–5.8, p = 0.015), one (OR 5.0, CI
2.6–9.8, p < 0.000) or more than one (OR 7.9, CI 3.9–15.9,
p < 0.000) SLDP-episode were associated with being on SL
Table 2 Function at MMR start (IN) and completed MMR (OUT) n = 406
NO Part-time Full- time
n = 123 n = 214 n = 69
IN OUT IN OUT IN OUT
n % n % p1 n % n % p2 n % n % p3 p4
Pain b280 <0.000 <0.000 <0.000
No 0 0 7 5.7 1 0.5 3 1.4 1 1.4 0 0
Mild 23 18.7 49 39.8 20 9.3 41 19.2 2 2.9 11 15.9
Moderate 56 45.5 49 39.8 90 42.1 90 42.1 22 31.9 23 33.3
Severe 43 35.0 18 14.6 102 47.7 77 36.0 42 60.9 33 47.8
Total 1 0.8 0 0 1 0.5 2 0.9 2 2.9 2 2.9
Missing value 1 0.5
Improved 66 53.7 53 24.9 19 27.5 <0.000
Unchanged 48 39.0 151 70.9 44 63.8
Impaired 9 7.3 9 4.2 6 8.7
Exerc tolerance b455 <0.000 <0.000 <0.000
No 26 21.1 50 40.7 27 12.6 38 17.8 7 10.1 10 14.5
Mild 32 26.0 33 26.8 48 22.4 70 32.7 12 17.4 16 23.2
Moderate 43 35.0 28 22.8 94 43.9 83 38.8 21 30.4 21 30.4
Severe 20 16.3 11 8.9 40 18.7 18 8.4 25 36.2 19 27.5
Total 2 1.6 1 0.8 5 2.3 4 1.9 4 5.9 3 4.3
Missing value 1 0.5
Improved 51 41.5 70 32.9 19 27.5 0.054
Unchanged 64 52.0 125 53.6 44 63.8
Impaired 8 6.5 18 8.5 6 8.7
Mobility b710 <0.000 <0.000 <0.000
No 7 5.7 21 17.1 13 6.1 24 11.2 5 7.2 4 5.8
Mild 46 37.4 61 49.6 52 24.3 67 31.3 8 11.6 16 23.2
Moderate 39 31.7 22 17.9 75 35.0 70 32.7 26 37.7 24 34.8
Severe 20 16.3 14 11.4 47 22.0 39 18.2 21 30.4 17 24.6
Total 0 0 0 0 1 0.5 0 0 2 2.9 2 2.9
Missing value 11 8.9 5 4.1 26 12.1 14 6.5 7 10.1 6 8.7
Improved 41 38.0 49 27.4 12 20.7 0.037
Unchanged 61 56.5 114 63.7 43 74.1
Impaired 6 5.6 16 8.9 3 5.2
p1 = Changes in function between rehab start and completed rehab, within the group with no SLDP the year before; p2 = Changes in function between rehab start and
completed rehab, within the group with part-time SLDP the year before; p3 = Changes in function between rehab start and completed rehab, within the group with full-
time SLDP the year before; p4 = Chi-2 trend. Comparisons in improvement between all three groups.
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ciated with not being on SL (OR 0.5, CI 0.3–0.9, p = 0.028)
and having an EQ-5D ≥ 0.5 at MMR start was not
significantly associated with not being on sick leave at
month four after MMR, but with a low p-value (OR 0.6,
CI 0.3–1.0, p = 0.061) (Table 4).
Discussion
On the results
Focus for the National rehabilitation program was to
promote work ability. In this study 73.6% of the patientswho were not on SLDP the year before MMR rated work
ability as limited at MMR start. After MMR in this
group only 34.1% reported work ability limitations. The
results in this study indicate that MMR is effective also
for patients not on SL and we believe that it is important
to focus on patients who perceive work ability limita-
tions but are not at SL. Often, work ability limitations
are compared to being on sick leave or disability pen-
sion, but there are no perfect matches between sick leave
and work ability limitations [38]. Being older than
40 years (both males and females) in our study was
Figure 4 Net sick leave days four month before until four month after multimodal rehabilitation (MMR)start. Mean net sick leave days
four month before until four month after MMR start in patients with EQ-5D < 0.5 (n = 253 ) respectively ≥0.5 (n = 153 ) at MMR start. 95%
confidence interval (CI).
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MMR which was unexpected as function and HRQoL is
expected to decrease in higher age. Earlier studies have
indicated that older women have better quality of life
[39], but population surveys indicate that EQ-5D
decreases with age [32]. It is important to take into ac-
count for older persons their need for rehabilitation,
since today they are expected to work at higher age and
are a requested resource in society. In this study, levels
of education or gender did not influence SL at month
four after MMR or EQ-5D at three month follow-up but
previous studies indicate that low education has an im-
pact on RTW [40].
Function, HRQoL and work ability and sick leave were
used as patient reported out-comes in this study. At MMRFigure 5 Self-reported work ability at multimodal rehabilitation (MMR
Self-reported work ability (limited or not limited) the last week, while at wo
completed MMR (OUT) and follow up (FU) in employed/self-employed pat
the year before MMR. No SLDP: n = 87 (IN), n = 88 (OUT), n = 93 (FU); Part-t
n = 18 (IN), n = 18 (OUT), n = 15 (FU).start, more than half of the patients had EQ-5D < 0.5. In
general, EQ-5D improved during MMR, but still patients
in this study had low EQ-5Ds and did not reach the level
for a Swedish normal population [31,32]. The group with
no SLDP the year before MMR start was at completed
MMR close to a suggested cut-off value for having work
ability [41]. Having an EQ-5D ≥ 0.5 at MMR start, was not
significantly associated with not being on sick leave at
month four after MMR start but previous studies indicate
that EQ-5D can predict RTW for patients with neck/back
pain, on sick leave for > 28 days [41] and we suggest that
EQ-5D can be used as a predictor of future sick leave and
when planning rehabilitation.
Having SLDP the year before MMR, was associated
with having an EQ-5D < 0.5 at three month follow-up. In) start, completed MMR and at three month follow-up.
rk and due to pain, at multimodal rehabilitation (MMR)start (IN),
ients with no, part-time or full-time sick leave/disability pension (SLDP)
ime SLDP: n = 151 (IN), n = 144 (OUT), n = 140 (FU); Full-time SLDP:
Table 3 Regression models for EQ–5D ≥0.5 at three months follow–up
Crude Model Model I Model II
R2 = 0.192 R2 = 0.279
OR CI OR CI OR CI
Sensation of pain (b280) IN 1
Moderate 0.451 0.189–1.076
Severe/total 0.123 0.503–0.290
Sensation of pain (b280) OUT 1 1 1
Moderate 0.430 0.242–0.763 0.632 0.337–1.183 0.678 0.350–1.314
Severe/total 0.117 0.064–0.212 0.219 0.114–0.423 0.232 0.113–0.474
Problems with exercise tolerance functions (b355) IN 1 1 1
Moderate 0.515 0.319–0.830 0.574 0.330–0.998 0.529 0.296–0.847
Severe/total 0.232 0.134–0.400 0.359 0.189–0.682 0.417 0.211–0.822
Problems with exercise tolerance functions (b355) OUT 1
Moderate 0.536 0.343–0.839
Severe/total 0.195 0.103–0.369
Problems with mobility in joints function (b710) IN 1
Moderate 0.752 0.456–1.240
Severe/total 0.404 0.233–0.702




Sex (man) 0.805 0.494–1.311
SLDP–year before (no) 1 1
Part–time 0.733 0.459–1.171 1.216 0.681–2.174
Full–time 0.264 0.142–0.491 0.419 0.194–0.907
Married (yes) 1
no 1.134 0.762–1.687
Born in Sweden 1 1
Not 0.277 0.171–0.447 0.372 0.214–0.645
Age < 40 1 1
Age ≥40 1.220 0.845–1.960 1.835 1.077–3.127
Education no/elementary school 1




Multivariate adjusted odds ratios (OR) and 95% confidence interval (CI). Crude model: univariate regression model, n = 406. Model I: backward regression model
for functions, n = 345. Model II: backward adjusted OR for baseline demographics, n = 345. Significant OR and CI in bold face (p = <0.05). MMR start (IN), completed
MMR (OUT). SLDP = sick leave/disability pension year before MMR.
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http://www.biomedcentral.com/1471-2474/14/57this study the group with no SLDP the year before
MMR differentiate, but in an RCT, Shiri et al. [42] found
that part-time sick leave at an early stage, may be advan-
tageous to improve perceived HRQoL. SLDP-episodes
the year before MMR was associated with being on sick-
leave at month four after MMR start. This indicates that
SLDP-history is important information, when planning
for rehabilitation and sick leave and we believe that it is
easy for patients to remember if they have had anyprevious SLDP-episodes. Earlier studies support that
SLDP is a predictor for RTW [40,43].
An ICF-based structure is recommended when report-
ing about different health states in relation to MSD [44]
but there is need for an improved operationalisation of
the ICF, to obtain a more solid reliability [45]. In this
study, three different functions were assessed. In general,
functions improved after MMR. Functional limitations
at completed MMR were associated with SL month four
Table 4 Regression models for sick leave month four after MMR start
Crude Model Model I Model II
R2 = 0.141 R2 = 0.311
OR CI OR CI OR CI
Sensation of pain (b280) IN 1
Moderate 2.441 1.098–5.426
Severe/total 3.724 1.688–8.214
Sensation of pain (b280) OUT 1
Moderate 2.356 1.344–4.131
Severe/total 4.200 2.320–7.601
Problems with exercise tolerance functions (b355) IN 1
Moderate 2.083 1.273–3.410
Severe/total 2.375 1.335–4.224
Problems with exercise tolerance functions (b355) OUT 1 1 1
Moderate 2.906 1.814–4.655 2.160 1.257–3.712 2.195 1.216–3.962
Severe/total 1.653 0.828–3.298 0.748 0.324–1.728 0.979 0.397–2.415
Problems with mobility in joints function (b710) IN 1
Moderate 1.584 0.938–2.677
Severe/total 2.358 1.306–4.255
Problems with mobility in joints function (b710) OUT 1 1 1
Moderate 2.381 1.429–3.966 2.046 1.151–3.637 1.674 0.890–3.149
Severe/total 3.689 2.000–6.805 3.051 1.502–6.200 2.644 1.206–5.795
EQ–5D <0.5 IN 1 1 1
≥ 0.5 0.515 0.330–0.802 0.608 0.366–1.009 0.587 0.336–1.026
EQ–5D <0.5 OUT 1
≥ 0.5 0.423 0.274–0.652
Sex 1
Sex (man) 0.712 0.417–1.215
SLDP–episode year before (no) 1 1
One episode 5.898 3.252–10.696 4.998 2.562–9.750
> 1 episode 8.494 4.604–15.683 7.869 3.894–15.900
Married (yes) 1
no 1.338 0.876–2.045
Born in Sweden 1
not 1.526 0.929–2.508
Age < 40 1 1
≥ 40 0.736 0.539–1.302 0.527 0.298–0.932
Education no/elementary school 1




Multivariate adjusted odds ratios (OR) and 95% confidence interval (CI). Crude model: univariate regression model, n = 361. Model I: backward regression model
for functions, n = 306. Model II: backward adjusted OR for baseline demographics, n = 306. Significant OR and CI in bold face (p = <0.05). MMR start (IN), completed
MMR (OUT). SLDP = sick leave/disability pension year before MMR.
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http://www.biomedcentral.com/1471-2474/14/57after MMR. This is in line with how work ability and the
need for sick leave should be assessed in Sweden; not
based on the diagnosis rather if there are functional lim-
itations that affect work ability. What we do not know is
how these functional limitations are related to the patient’sactual work demands [18,19]. Lydell et al. [43] has found
that functional capacity, among other factors, was a pre-
dictor of long-term RTW. Planning for using assessments
involving such predictors, may be beneficial in planning a
sick leave period, at an early stage.
Stigmar et al. BMC Musculoskeletal Disorders 2013, 14:57 Page 11 of 12
http://www.biomedcentral.com/1471-2474/14/57Methodological strengths and weaknesses
A major strength in this study is that the final cohort
was drawn from a cohort of all patients that were direc-
ted to MMR in Skåne County, which is a region that is
representative for the whole Swedish population, in
terms of demographics. Data is continuously ascertained
from different PHC centres, which all used the same
questionnaires and were automatically transferred to
SHCR. At the time for this study, no matched controls
were available.
In this study, EQ-5D was applied, which is widely used
and has been found to have a good prediction of RTW
for sick-listed patients with neck/back pain [41]. No
Swedish tariff for EQ-5D is today available and mainly a
British tariff is used [31-33] but recently, a Danish tariff
has been introduced [46]. A concern would be that the
UK tariffs and the potential tariffs for Swedish data dif-
fer. In 2011, a new version, offering five levels of answer-
ing alternatives, was introduced [47].
The question about self-rated work ability was answered
by those who were employed/self-employed. This is espe-
cially significant in the group with full-time SLDP, where
75.4% were un-employed at MMR start. Previous studies
show that self-reported work ability, give reliable informa-
tion concerning patients work ability and can predict
future sick leave [48,49] and a sustainable RTW [50]. We
suggest that the single-item question from Work Ability
Index (WAI) should be used.
Conclusions
Both patients on SLDP or at risk for SLDP seem to
benefit from MMR. We believe that it is important to
offer MMR also to patients ≥ 40 years old and also focus
patients that perceive work ability limitations, and are at
risk for work disability, all though not yet at sick leave.
Focusing EQ-5D and self-rated work ability, could con-
tribute to create tailor-made interventions and well-
defined, time- coordinated interventions may prevent
future sick leave and increase HRQoL. Still, there is need
to find out what components in MMR that are actually
efficient.
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